Bangkok Genomics Innovation Public Company Limited (BKGI.BK)

THB 1.99

(-1.49%)

Market Cap (In THB)

1.19 Billion

Revenue (In THB)

245.38 Million

Net Income (In THB)

32.14 Million

Avg. Volume

8.9 Million

Currency
THB
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.67-5.65
PE
-
EPS
-
Beta Value
0.0
ISIN
THB972010003
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Mr. Xiaohan Wang
Employee Count
-
Website
-
Ipo Date
2024-03-18
Details
Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products). Its segments include Scientific testing services which generates key revenue, and Sale of goods.